Authors: Gruzintsev, A. N., Volkov, V. T., Khodos, I. I., Nikiforova, T. V., Kovalʼchuk, M. N.

Source: Russian Microelectronics. May 01, 2002 31(3):200-205

Availability: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=fulltext&D=ovft&CSC=Y&NEWS=N&SEARCH=00131724-200231030-00008.an

Authors: Krivelevich, S. A., Makovi&ibreve;chuk, M. I., Selyukov, R. V.

Source: Physics of the Solid State; Jan2005, Vol. 47 Issue 1, p9-12, 4p

Subject Terms: COLLISIONS (Nuclear physics), SILICON, RARE earth metals, PARTICLES (Nuclear physics), POROUS silicon, RARE earths

Authors: Esaulenko, E. E., Khil Chuk, M. A., Iliya Bykov

Source: Europe PubMed Central
ResearcherID

Access URL: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6c49ce68b0967191ebdb94c1ca52eb65
http://europepmc.org/abstract/med/24640157

Authors: Koval Chuk, M. L., Kolisnyk, M. G., Oleg Kopach, Balazvuk, V. N., Nykonyuk, Y. S., Rarenko, A. I., Salan, V. P.

Source: Scopus-Elsevier

Access URL: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6f3315ae1351ed6d7800661780d0af05
http://www.scopus.com/inward/record.url?eid=2-s2.0-63749123601&partnerID=MN8TOARS

Authors: Molodkin, V. B., Koval Chuk, M. V., Machulin, V. F., Nizkova, G. I., Muhamedjanov, E. H., Lizunova, S. V., Klad Ko, V. P., Dmitriev, S. V., Zabolotnyy, I. M., Irkha, N. P., Brovchuk, S. M., Vasyl Kladko, Lizunov, V. V., Katasonov, A. A., Rudnyts Ka, I. I., Kharchenko, V. S., Blagov, A. E., Molodkin, V. V., Pervak, K. V., Lekhnyak, R. V.

Source: Scopus-Elsevier

Access URL: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::21f3c6363cb115ffb833b6182c746469
http://www.scopus.com/inward/record.url?eid=2-s2.0-84872406420&partnerID=MN8TOARS

Authors: Miramonti, Lino, Altenmuller, K., Appel, S., Atroshchenko, V., Bagdasarian, Z., Basilico, D., Bellini, G., Benziger, J., Bick, D., Bolognini, I., Bonfini, G., Bravo, D., Caccianiga, B., Calaprice, F., Caminata, A., Caprioli, S., Carlini, M., Cavalcante, P., Cavanna, F., Chepurnov, A., Choi, K., Collica, L., Davini, S., Derbin, A., Ding, X. F., Ludovico, A. Di, Di Noto, L., Drachnev, I., Fomenko, K., Formozov, A., Franco, D., Gabriele, F., Galbiati, C., Gschwender, M., Ghiano, C., Giammarchi, M., Goretti, A., Gromov, M., Guffanti, D., Hagner, C., Houdy, T., Hungerford, E., Ianni, Aldo, Ianni, Andrea, Jany, A., Jeschke, D., Kobychev, V., Korablev, D., Korga, G., Lachenmaier, T., Laubenstein, M., Litvinovich, E., Lom-Bardi, F., Lombardi, P., Ludhova, L., Lukyanchenko, G., Lukyanchenko, L., Machulin, I., Manuzio, G., Marcocci, S., Maricic, J., Martyn, J., Meroni, E., Meyer, M., Miramonti, L., Misiaszek, M., Mura-Tova, V., Neumair, B., Oberauer, L., Opitz, B., Orekhov, V., Ortica, F., Pallavicini, M., Papp, L., Penek, O., Pietrofaccia, L., Pilipenko, N., Pocar, A., Porcelli, A., Raikov, G., Ranucci, G., Razeto, A., Re, A., Red-Chuk, M., Romani, A., Rossi, N., Rottenanger, S., Schönert, S., Semenov, D., Skorokhvatov, M., Smirnov, O., Albert Sotnikov, Stokes, L. F. F., Suvorov, Y., Tartaglia, R., Testera, G., Thurn, J., Toropova, M., Un-Zhakov, E., Vishneva, A., Vogelaar, R. B., Von Feilitzsch, F., Weinz, S., Wojcik, M., Wurm, M., Yokley, Z., Zaimidoroga, O., Zavatarelli, S., Zuber, K., Zuzel, G.

Source: INSPIRE-HEP

Access URL: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::11119471d30e7e6df5ccf82ff033d2db
http://inspirehep.net/record/1717480

Authors: Pogromov, A. P., Galina Diukova, Koval Chuk, M. O., Strokov, I. A., Akhmedzhanova, L. T., Generozov, E. V., Markin, S. S.

Source: Scopus-Elsevier

Access URL: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::14d73393e21d21cfb86de93bd79704cb
http://www.scopus.com/inward/record.url?eid=2-s2.0-77949903529&partnerID=MN8TOARS

Authors: Lodish M, Dagalakis U, Chen CC, Sinaii N, Whitcomb P, Aikin A, Dombi E, Marcus L, Widemann B, Fox E, Chuk M, Balis F, Wells S Jr, Stratakis CA, Lodish, Maya, Dagalakis, Urania, Chen, Clara C, Sinaii, Ninet, Whitcomb, Patricia, Aikin, Alberta

Source: Journal of Clinical Endocrinology & Metabolism; 2012 Feb, Vol. 97 Issue 2, pE207-12, 1p

Authors: Chuk, M., Kube, P., Sandell, P.

Source: Forest Ecology & Management. Oct1986, Vol. 16 Issue 1-4, p411. 0p.

Subject Terms: *Fertilizers, *Biomass production

Authors: Sandell, P., Chuk, M., Kube, P.

Source: Forest Ecology & Management; Oct1986, Vol. 16 Issue 1-4, p411, 0p

Subject Terms: FERTILIZERS, BIOMASS production

Authors: Saung MT; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Pelosof L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Casak S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Donoghue M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Lemery S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Yuan M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Rodriguez L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Schotland P; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Chuk M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Davis G; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Goldberg KB; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Theoret MR; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Fashoyin-Aje L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Source: The oncologist [Oncologist] 2021 Sep; Vol. 26 (9), pp. 797-806. Date of Electronic Publication: 2021 Jun 10.

Publication Type: Journal Article; Review

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Authors: Stewart MD; Friends of Cancer Research. Electronic address: mstewart@focr.org., McCall B; Genentech, A Member of the Roche Group., Pasquini M; Medical College of Wisconsin, Center for International Blood and Marrow Transplant Research., Yang AS; Xencor., Britten CD; Amgen., Chuk M; Food and Drug Administration., De Claro RA; Food and Drug Administration., George B; Food and Drug Administration., Gormley N; Food and Drug Administration., Horowitz MM; Medical College of Wisconsin, Center for International Blood and Marrow Transplant Research., Kowack E; Xencor., McCoy C; Bristol Myers Squibb., Morrow PK; Amgen., Okoye E; Regeneron Pharmaceuticals., Ricafort R; Bristol Myers Squibb., Rossi J; CERo Therapeutics., Sharon E; National Cancer Institute., Theoret M; Food and Drug Administration., Vegni F; Bristol Myers Squibb., Yu T; Amgen., Allen J; Friends of Cancer Research.

Source: Cytotherapy [Cytotherapy] 2022 Jul; Vol. 24 (7), pp. 742-749. Date of Electronic Publication: 2022 Feb 23.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE

MeSH Terms: Cytokine Release Syndrome*/etiology , Immunotherapy*/adverse effects , Neoplasms*/therapy, Antibodies, Bispecific ; Clinical Trials as Topic ; Humans ; Immunotherapy, Adoptive/adverse effects

Authors: Leong R; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA., Liu Q; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA., Li L; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA., Liu J; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA., Ren YR; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA., Lee P; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA., Chuk M; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland, USA., Reaman G; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland, USA., Wang Y; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.

Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 Apr; Vol. 111 (4), pp. 956-963. Date of Electronic Publication: 2021 Nov 21.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

MeSH Terms: Medical Oncology* , Neoplasms*/drug therapy, Adolescent ; Adult ; Body Weight ; Child ; Clinical Trials as Topic ; Humans ; Pharmaceutical Preparations ; United States ; United States Food and Drug Administration

Authors: Kim J; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Nair A; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Keegan P; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Beaver JA; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Kluetz PG; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Pazdur R; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Chuk M; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Blumenthal GM; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Source: The oncologist [Oncologist] 2020 Apr; Vol. 25 (4), pp. 348-354. Date of Electronic Publication: 2019 Dec 17.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Authors: Kim J; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA janice.kim@fda.hhs.gov., Nair A; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Keegan P; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Beaver JA; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Kluetz PG; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Pazdur R; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Chuk M; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Blumenthal GM; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Source: The oncologist [Oncologist] 2019 Dec 17. Date of Electronic Publication: 2019 Dec 17.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Authors: Norsworthy KJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA. kelly.norsworthy@fda.hhs.gov., Avagyan A; Acumen LLC, Burlingame, CA, USA., Bird ST; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Li Y; Acumen LLC, Burlingame, CA, USA., Akhtar S; Acumen LLC, Burlingame, CA, USA., Liao J; Acumen LLC, Burlingame, CA, USA., Wernecke M; Acumen LLC, Burlingame, CA, USA., Deisseroth AB; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Chuk M; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, MD, USA., MaCurdy TE; Acumen LLC, Burlingame, CA, USA.; Department of Economics, Stanford University, Stanford, CA, USA., Swain R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Kelman JA; Centers for Medicare & Medicaid Services, Washington, DC, USA., Farrell AT; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., de Claro RA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Pazdur R; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, MD, USA., Blumenthal G; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, MD, USA., Graham DJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.

Source: Leukemia [Leukemia] 2020 Nov; Vol. 34 (11), pp. 3082-3084. Date of Electronic Publication: 2020 Jun 09.

Publication Type: Letter; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

MeSH Terms: Antineoplastic Combined Chemotherapy Protocols/*adverse effects , Arsenic Trioxide/*adverse effects , Leukemia, Promyelocytic, Acute/*epidemiology , Neoplasms, Second Primary/*epidemiology , Neoplasms, Second Primary/*etiology, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Arsenic Trioxide/administration & dosage ; Female ; Humans ; Incidence ; Leukemia, Promyelocytic, Acute/drug therapy ; Leukemia, Promyelocytic, Acute/mortality ; Male ; Medicare ; Prognosis ; SEER Program ; United States/epidemiology

Authors: Snider J; Donnelly Centre, University of Toronto, Toronto, Ontario, Canada., Hanif A, Lee ME, Jin K, Yu AR, Graham C, Chuk M, Damjanovic D, Wierzbicka M, Tang P, Balderes D, Wong V, Jessulat M, Darowski KD, San Luis BJ, Shevelev I, Sturley SL, Boone C, Greenblatt JF, Zhang Z, Paumi CM, Babu M, Park HO, Michaelis S, Stagljar I

Source: Nature chemical biology [Nat Chem Biol] 2013 Sep; Vol. 9 (9), pp. 565-72. Date of Electronic Publication: 2013 Jul 07.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101231976 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4469 (Electronic) Linking ISSN: 15524450 NLM ISO Abbreviation: Nat Chem Biol Subsets: MEDLINE

Authors: Khozin S; Center for Drug Evaluation and Research, Food and Drug Administration, New Hampshire Avenue, Silver Spring, Maryland 20993, USA., Chuk M; Center for Drug Evaluation and Research, Food and Drug Administration, New Hampshire Avenue, Silver Spring, Maryland 20993, USA., Kim T; Center for Drug Evaluation and Research, Food and Drug Administration, New Hampshire Avenue, Silver Spring, Maryland 20993, USA., Kim G; Center for Drug Evaluation and Research, Food and Drug Administration, New Hampshire Avenue, Silver Spring, Maryland 20993, USA., Pazdur R; Center for Drug Evaluation and Research, Food and Drug Administration, New Hampshire Avenue, Silver Spring, Maryland 20993, USA., De S; Office of Surveillance and Epidemiology, Food and Drug Administration, Silver Spring, Maryland 20993, USA., Sahoo S; Office of Surveillance and Epidemiology, Food and Drug Administration, Silver Spring, Maryland 20993, USA.

Source: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2016 Sep 29; Vol. 15 (10), pp. 670-1.

Publication Type: News

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Internet ISSN: 1474-1784 (Electronic) Linking ISSN: 14741776 NLM ISO Abbreviation: Nat Rev Drug Discov Subsets: MEDLINE

MeSH Terms: Drug Approval*, Computers/*standards , Device Approval/*standards , Research Report/*standards , United States Food and Drug Administration/*standards, Computers/trends ; Humans ; Research Report/trends ; Safety ; United States ; United States Food and Drug Administration/trends

Authors: Jarow JP; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Casak S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Chuk M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ehrlich LA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Khozin S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. sean.khozin@fda.hhs.gov.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2016 May 01; Vol. 22 (9), pp. 2111-3. Date of Electronic Publication: 2016 Jan 18.

Publication Type: Journal Article

Journal Info: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

MeSH Terms: Drugs, Investigational/*adverse effects , Drugs, Investigational/*therapeutic use, Drug Approval/methods ; Humans ; Investigational New Drug Application/methods ; Medical Oncology/methods ; United States ; United States Food and Drug Administration

Authors: Maibach EW; Center for Climate Change Communication, George Mason University, Fairfax, Virginia, United States of America. emaibach@gmu.edu, Chadwick A, McBride D, Chuk M, Ebi KL, Balbus J

Source: PloS one [PLoS One] 2008 Jul 30; Vol. 3 (7), pp. e2838. Date of Electronic Publication: 2008 Jul 30.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: Electronic Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE